Results 71 to 80 of about 1,693 (197)

Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo‐Controlled, Double‐Blind, Crossover Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4671-4682, June 2026.
ABSTRACT Introduction Oxytocin is expressed throughout the small intestine, suggesting a role for oxytocin in postprandial metabolism. Accordingly, single‐dose intranasal oxytocin reduces food intake and improves glucose tolerance. We investigated the effects of a continuous intravenous oxytocin infusion on ad libitum food intake, appetite sensations ...
Ida M. Gether   +13 more
wiley   +1 more source

Atosiban, an oxytocin receptor blocking agent: pharmacokinetics and inhibition of milk ejection in dairy cows.

open access: yes, 1999
Plasma concentrations of the oxytocin receptor blocking agent Atosiban were measured at 2, 4, 10, 15 and 20 min after injection of 5, 10, 20 and 50 micrograms Atosiban/kg body weight in six dairy cows.
Bruckmaier RM   +3 more
core   +1 more source

Pathogenesis of Adenomyosis: An Integrated Review of Cellular Origins, Molecular Mechanisms, and Intersecting Diseases

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 7, April 2026.
ABSTRACT Adenomyosis is a prevalent disorder of the archimetra, historically conflated with endometriosis but possessing a unique pathobiological trajectory. This review synthesises current molecular evidence to propose a unified mechanistic framework initiated by tissue injury and repair (TIAR), aberrant stem cell activation, or de novo metaplasia ...
Jiang Yang   +6 more
wiley   +1 more source

Image_4_Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis.tif

open access: yes, 2023
BackgroundRepeated embryo implantation failure (RIF) posed a significant challenge in assisted reproduction. Evidence of its therapeutic effectiveness including atosiban used around embryo transfer to improve pregnancy outcomes in RIF patients undergoing
Guicheng Xia (11166447)   +3 more
core   +1 more source

In the gravid human uterus, oxytocin induces smooth muscle cell contraction via transient receptor potential vanilloid 4 channel activation

open access: yesThe Journal of Physiology, Volume 604, Issue 7, Page 3135-3158, 1 April 2026.
Abstract figure legend In gravid human uterus smooth muscle, the oxytocin receptor (OXTR) and transient receptor potential vanilloid 4 (TRPV4) calcium channel colocalize at <40 nm by proximity ligation. TRPV4 is necessary for oxytocin‐induced calcium influx and contractility in uterine smooth muscle cells.
Daiana Fornes   +4 more
wiley   +1 more source

Atosiban: a comprehensive approach to preterm labour management [PDF]

open access: yes
Preterm birth (PTB) continues to be a leading cause of neonatal mortality and long-term complications globally, reinforcing the need for effective and safe tocolytic treatments.
Ganiga, Rishima   +2 more
core   +1 more source

Cervical incompetence with fetal bladder prolapse: new therapeutic options

open access: yesМедицинский совет, 2015
The article tells about the results of management of women with cervical incompetence accompanied by fetal bladder prolapse into the cervical canal or the upper third of the vagina at 24-25 weeks of gestation.
N. K. Tetrusashvili   +2 more
doaj   +1 more source

Unlocking Biomolecule Modification with Light‐Promoted Photocatalyst‐Free Approaches: Current Tools, Challenges, and Perspectives

open access: yesChemistryEurope, Volume 4, Issue 1, January 2026.
This Perspective focuses on photocatalyst‐free, photoinduced modifications of biomolecules, emphasizing transformations mediated by electron donor–acceptor complexes. Mechanistic aspects, current limitations, and future opportunities are discussed, providing insight into the field of bioconjugation.
Milene Hornink   +3 more
wiley   +1 more source

Image_3_Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis.tif

open access: yes, 2023
BackgroundRepeated embryo implantation failure (RIF) posed a significant challenge in assisted reproduction. Evidence of its therapeutic effectiveness including atosiban used around embryo transfer to improve pregnancy outcomes in RIF patients undergoing
Guicheng Xia (11166447)   +3 more
core   +1 more source

Treatment of preterm labor with the oxytocin antagonist atosiban: a double-bind, randomized, controlled comparison with salbutamol

open access: yes, 2001
Objective: To compare the efficacy and safety of atosiban and salbutamol in the treatment of preterm labor. Study design: A multicenter, double-blind, double-placebo, randomized, controlled trial.
Magnin, G.   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy